All Articles

While US travel faces turbulence, Ontario International Airport is soaring with a 37% international surge, solidifying its role as an economic engine.

Avista's hire of Tom Orr isn't just a new title. It signals a critical shift in private equity, where deep manufacturing expertise is the new currency.

PTC Therapeutics' Sephience isn't just another drug; it's a potential life-changer for PKU patients, promising to ease the burden of a lifelong restrictive diet.

As AN2 Therapeutics bets its future on novel boron-based drugs, the appointment of Dr. Cameron Trenor signals a critical shift from promise to proof.

Flexpoint's rapid scaling and sale of ArtesRx to Linden reveals a high-stakes model for specialized care. But can profit motives and patient needs coexist?

Stunning drill results from Chile's Atacama region are more than just data; they are reshaping Hot Chili's Costa Fuego project into a global copper contender.

As a key forum convenes in Los Alamos, companies like Verdera Energy are betting big on domestic uranium. Is this the dawn of a U.S. nuclear renaissance?

FDA clearance for Roche's pTau217 blood test isn't just a clinical win; it's a strategic move to dominate a $27B market by making diagnosis simple and scalable.

Accessibility Services, Inc. launched a Bluetooth adapter today, but the real story is a lesson in resilient innovation and restoring human dignity.

In a classic Brad Jacobs move, QXO hires Honeywell veteran Ken West, an M&A integration expert, to operationalize its massive acquisition spree.

Sealed Air's new ProPad Mini isn't just a machine; it’s a response to e-commerce's demand for speed, space, and sustainability in one compact package.

LB Capital's planned $30M raise highlights the booming litigation finance market, a nexus of capital and justice that offers lifelines to plaintiffs.

North America faces a crippling shortage of skilled tradespeople. One metal supplier is doubling down on a solution: investing directly in the next generation.

Betable and Delasport's new partnership is more than a deal; it's a look at the future of iGaming infrastructure and the systems built to win a global market.

At WRC 2026, Galaxea AI ditched flashy stunts for real-world reliability, showcasing adaptable robots ready for factories and warehouses today.

From explorer to producer, PDI Gold's name change and share consolidation signal a bold new chapter. But can it navigate financial hurdles and regional risks?

As Royal Jordanian embarks on a massive fleet and network expansion, it's betting on a new digital backbone from Ramco Systems to power its growth.

Estonian developer Hepsor AS is offering a 9.50% unsecured bond. We analyze if this high-yield opportunity is a strategic masterstroke or a risky wager.

A new partnership between a top R&D center and a health sciences university aims to fuse AI with biomaterials, promising medical breakthroughs for Hong Kong.

Takeda's ORZEYFUL, a first-in-class orexin agonist, wins approval in Japan, offering the first treatment for the root cause of Narcolepsy Type 1.